CD4 and inflammatory bowel disease: In this regard, Kwon et al recently observed that administration of the probiotic mixture ITR5 results in an enhancement of the CD4+FOXP3+ Treg population, and suppression of the progression of murine experimental inflammatory bowel disease, atopic dermatitis and rheumatoid arthritis [62].